|Articles|June 1, 2002
ISTA acquires rights to 3 ophthalmic compounds
Irvine, CA-ISTA Pharmaceuticals, Irvine, CA, entered into an agreement with AcSentient Inc. under which ISTA will acquire rights to three late-stage ophthalmology compounds.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves Rayner’s RayOne EMV Toric intraocular lens
2
Avisi Technologies’ investigational device exemption for VisiPlate approved by FDA
3
NeuroOp Guru: When proptosis isn’t thyroid eye disease
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5